Fostering the development of AI-enhanced technologies to support healthy aging in place of choice for older adults and individuals with Alzheimer’s disease.
Using AI to Repurpose Small Molecules to Target Amyloid-tau Interactions in AD
Investigators:
Jeremy Linsley, Operant BioPharma
Empowering Caregivers of Individuals with Cognitive Impairment to Make Safe Nonprescription Drug Decisions
Investigators:
Eun Kyoung Choe, University of Maryland
Low-Cost mHealth Technology for Objectively Assessing Hearing Loss at Home
Investigators:
Wenyao Xu, Auspex Medix
Wei Sun, University at Buffalo
